细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 3439人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979078, encodeId=64d619e907855, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=ASCO GU 2021: 纳武利尤单抗+伊匹单抗联合治疗转移性肾细胞癌的疗效, objectType=article, longId=207272, objectId=f72f20e272b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f72f20e272b6, replyNumber=0, likeNumber=191, createdTime=2021-04-14, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f72f20e272b6, moduleTitle=ASCO GU 2021: 纳武利尤单抗+伊匹单抗联合治疗转移性肾细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f72f20e272b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979013, encodeId=f5e519e901366, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet Oncol：肾透明细胞癌与肥胖悖论相关的转录组特征分析, objectType=article, longId=199538, objectId=8bfb199538ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bfb199538ea, replyNumber=0, likeNumber=75, createdTime=2021-04-17, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bfb199538ea, moduleTitle=Lancet Oncol：肾透明细胞癌与肥胖悖论相关的转录组特征分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bfb199538ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979002, encodeId=3bc019e9002e4, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Nat Commun：乳头状肾细胞癌的基因组和表观基因组进化史 , objectType=article, longId=197157, objectId=33ed19e157db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33ed19e157db, replyNumber=0, likeNumber=99, createdTime=2020-11-22, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33ed19e157db, moduleTitle=Nat Commun：乳头状肾细胞癌的基因组和表观基因组进化史 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33ed19e157db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979082, encodeId=ce2c19e9082e7, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BJU Int：系统靶向治疗复发性肾细胞癌中的辅助舒尼替尼治疗结果 , objectType=article, longId=207565, objectId=662820e56572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=662820e56572, replyNumber=0, likeNumber=71, createdTime=2022-02-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=662820e56572, moduleTitle=BJU Int：系统靶向治疗复发性肾细胞癌中的辅助舒尼替尼治疗结果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=662820e56572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979041, encodeId=b06219e9041c3, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Gastroenterology H: 慢性丙型肝炎病毒感染患者每日接受阿司匹林治疗与肝细胞癌发生风险的关系, objectType=article, longId=203043, objectId=935220304387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=935220304387, replyNumber=0, likeNumber=109, createdTime=2021-05-22, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=935220304387, moduleTitle=Clin Gastroenterology H: 慢性丙型肝炎病毒感染患者每日接受阿司匹林治疗与肝细胞癌发生风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=935220304387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978980, encodeId=fe6319e8980c4, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cell Death Dis：E2F1介导DDX11转录激活通过PI3K/AKT/mTOR通路促进肝细胞癌发生发展, objectType=article, longId=194080, objectId=4ff6194080ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ff6194080ed, replyNumber=0, likeNumber=59, createdTime=2020-09-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ff6194080ed, moduleTitle=Cell Death Dis：E2F1介导DDX11转录激活通过PI3K/AKT/mTOR通路促进肝细胞癌发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ff6194080ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978990, encodeId=36f719e899068, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatology：研究发现新的机制或可提高肝细胞癌患者的生存率, objectType=article, longId=194807, objectId=8a7519480ec3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a7519480ec3, replyNumber=0, likeNumber=45, createdTime=2021-04-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a7519480ec3, moduleTitle=Hepatology：研究发现新的机制或可提高肝细胞癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a7519480ec3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978993, encodeId=04b119e8993bf, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA, objectType=article, longId=195152, objectId=4ee01951523a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee01951523a, replyNumber=0, likeNumber=80, createdTime=2020-09-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee01951523a, moduleTitle=复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee01951523a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979059, encodeId=b31d19e905989, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Genet：Acyl-CoA硫酯酶8和11是透明细胞肾细胞癌的新型生物标志物, objectType=article, longId=205769, objectId=8e3c205e696e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e3c205e696e, replyNumber=0, likeNumber=67, createdTime=2021-05-16, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e3c205e696e, moduleTitle=Front Genet：Acyl-CoA硫酯酶8和11是透明细胞肾细胞癌的新型生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e3c205e696e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979072, encodeId=f50319e90722c, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生, objectType=article, longId=206848, objectId=152c206848c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=152c206848c1, replyNumber=0, likeNumber=112, createdTime=2021-09-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=152c206848c1, moduleTitle=Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=152c206848c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978954, encodeId=8b6f19e8954d5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Opdivo+Yervoy二线治疗肝细胞癌被FDA批准, objectType=article, longId=190102, objectId=724a19010294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=724a19010294, replyNumber=0, likeNumber=63, createdTime=2020-04-13, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=724a19010294, moduleTitle=Opdivo+Yervoy二线治疗肝细胞癌被FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=724a19010294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978975, encodeId=421419e897595, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=卵巢高血钙型小细胞癌误诊为颗粒细胞瘤1例, objectType=article, longId=193701, objectId=f80a193e016b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f80a193e016b, replyNumber=0, likeNumber=100, createdTime=2021-03-22, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f80a193e016b, moduleTitle=卵巢高血钙型小细胞癌误诊为颗粒细胞瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f80a193e016b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979049, encodeId=5a5119e90497e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancer Gene Therapy：肾细胞癌中STAT3调控miR93介导的细胞凋亡 , objectType=article, longId=204405, objectId=067f2044059f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=067f2044059f, replyNumber=0, likeNumber=67, createdTime=2021-05-30, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=067f2044059f, moduleTitle=Cancer Gene Therapy：肾细胞癌中STAT3调控miR93介导的细胞凋亡 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=067f2044059f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978950, encodeId=95f119e895002, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=超声诊断原发性肝细胞癌右房转移1例, objectType=article, longId=189567, objectId=5c0118956e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c0118956e43, replyNumber=0, likeNumber=219, createdTime=2020-08-01, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c0118956e43, moduleTitle=超声诊断原发性肝细胞癌右房转移1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c0118956e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979019, encodeId=c41719e901991, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cell Death & Disease：新研究揭示LncRNA CDKN2B-AS1/miR-141/cyclin D网络能调控肾细胞癌的肿瘤进展和转移, objectType=article, longId=200459, objectId=dabd200459a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dabd200459a9, replyNumber=0, likeNumber=66, createdTime=2021-01-20, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dabd200459a9, moduleTitle=Cell Death & Disease：新研究揭示LncRNA CDKN2B-AS1/miR-141/cyclin D网络能调控肾细胞癌的肿瘤进展和转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dabd200459a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978942, encodeId=f48d19e894247, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=ACS Appl Mater Interfaces：多功能纳米颗粒递送三氧化二砷可改善肝细胞癌的治疗, objectType=article, longId=188176, objectId=67f51881e6d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67f51881e6d8, replyNumber=0, likeNumber=87, createdTime=2020-05-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67f51881e6d8, moduleTitle=ACS Appl Mater Interfaces：多功能纳米颗粒递送三氧化二砷可改善肝细胞癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67f51881e6d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979047, encodeId=f26519e904768, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Sci Rep：一线阿西替尼治疗纺锤组织学转移性肾细胞癌效果较差, objectType=article, longId=203908, objectId=cbca2039086d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbca2039086d, replyNumber=0, likeNumber=66, createdTime=2020-12-27, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbca2039086d, moduleTitle=Sci Rep：一线阿西替尼治疗纺锤组织学转移性肾细胞癌效果较差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbca2039086d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978969, encodeId=ec7e19e89695a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet oncol：3期试验：UGN-101输尿管灌注治疗上尿路移行细胞癌癌的安全性和疗效, objectType=article, longId=193391, objectId=3c4019339127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c4019339127, replyNumber=0, likeNumber=56, createdTime=2020-06-17, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c4019339127, moduleTitle=Lancet oncol：3期试验：UGN-101输尿管灌注治疗上尿路移行细胞癌癌的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c4019339127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979017, encodeId=bab619e90176f, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Oncogene：YB1/EphA2信号增强能够促进肾细胞癌获得性舒尼替尼耐药和转移潜能, objectType=article, longId=200299, objectId=6f3d2002993b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f3d2002993b, replyNumber=0, likeNumber=88, createdTime=2020-09-27, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f3d2002993b, moduleTitle=Oncogene：YB1/EphA2信号增强能够促进肾细胞癌获得性舒尼替尼耐药和转移潜能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f3d2002993b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978984, encodeId=d9fa19e8984bf, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Oncogene：长非编码RNA PENG能够抑制透明细胞肾细胞癌的细胞增殖 , objectType=article, longId=194362, objectId=796d194362ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=796d194362ef, replyNumber=0, likeNumber=69, createdTime=2020-06-28, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=796d194362ef, moduleTitle=Oncogene：长非编码RNA PENG能够抑制透明细胞肾细胞癌的细胞增殖 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=796d194362ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

ASCO GU 2021: 纳武利尤单抗+伊匹单抗联合治疗转移性肾细胞癌的疗效

2021-04-14

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet Oncol：肾透明细胞癌与肥胖悖论相关的转录组特征分析

2021-04-17

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Nat Commun：乳头状肾细胞癌的基因组和表观基因组进化史

2020-11-22

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BJU Int：系统靶向治疗复发性肾细胞癌中的辅助舒尼替尼治疗结果

2022-02-03

heli0118 (审核中...)

前往app查看评论内容

#细胞癌#

Clin Gastroenterology H: 慢性丙型肝炎病毒感染患者每日接受阿司匹林治疗与肝细胞癌发生风险的关系

2021-05-22

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cell Death Dis：E2F1介导DDX11转录激活通过PI3K/AKT/mTOR通路促进肝细胞癌发生发展

2020-09-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatology：研究发现新的机制或可提高肝细胞癌患者的生存率

2021-04-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA

2020-09-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Genet：Acyl-CoA硫酯酶8和11是透明细胞肾细胞癌的新型生物标志物

2021-05-16

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生

2021-09-23

仁医06 (审核中...)

前往app查看评论内容

#细胞癌#

Opdivo+Yervoy二线治疗肝细胞癌被FDA批准

2020-04-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

卵巢高血钙型小细胞癌误诊为颗粒细胞瘤1例

2021-03-22

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancer Gene Therapy：肾细胞癌中STAT3调控miR93介导的细胞凋亡

2021-05-30

qingting (审核中...)

前往app查看评论内容

#细胞癌#

超声诊断原发性肝细胞癌右房转移1例

2020-08-01

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cell Death & Disease：新研究揭示LncRNA CDKN2B-AS1/miR-141/cyclin D网络能调控肾细胞癌的肿瘤进展和转移

2021-01-20

qingting (审核中...)

前往app查看评论内容

#细胞癌#

ACS Appl Mater Interfaces：多功能纳米颗粒递送三氧化二砷可改善肝细胞癌的治疗

2020-05-05

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Sci Rep：一线阿西替尼治疗纺锤组织学转移性肾细胞癌效果较差

2020-12-27

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet oncol：3期试验：UGN-101输尿管灌注治疗上尿路移行细胞癌癌的安全性和疗效

2020-06-17

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Oncogene：YB1/EphA2信号增强能够促进肾细胞癌获得性舒尼替尼耐药和转移潜能

2020-09-27

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Oncogene：长非编码RNA PENG能够抑制透明细胞肾细胞癌的细胞增殖

2020-06-28

科室
- - 订阅+
  - 更多科室
工具
服务